Sort
39,280 grants matching “leukemia”
Molecular Genetics of Fanconi Anemia
$1,948,381Oregon Health And Science University · P01 · FY2004 · HL
Studies of Populations Exposed to Diagnostic Medical Radiation
$1,947,269Amy Berrington · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Quality Assurance Review Center
$1,946,959Thomas J Fitzgerald · Univ Of Massachusetts Med Sch Worcester · U10 · FY2013 · CA
Molecular Mechanism of Action of Phorbol Ester
$1,946,385Peter Blumberg · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Roles and Regulation of wild-type and mutant forms of p53
$1,945,587Carol Prives · Columbia Univ New York Morningside · P01 · FY2017 · CA
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
$1,944,619Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2008 · CA
NK cells, their receptors and unrelated donor transplant
$1,944,102Jeffrey S Miller · University Of Minnesota · P01 · FY2011 · CA
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
$1,943,700Jonah B. Sacha · Oregon Health & Science University · R01 · FY2025 · AI
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
$1,942,544Fred Hutchinson Cancer Research Center · P01 · FY2005 · CA
Center for Molecular Imaging Research at MGH/HMS
$1,942,000Ralph Weissleder · Massachusetts General Hospital · P50 · FY2007 · CA
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain
$1,940,921James Jeffrey Sahn · 4e Therapeutics Inc. · U44 · FY2022 · NS
Biology and Transplantation of the Hematopoietic Stem Cell
$1,940,892John E Wagner · University Of Minnesota · P01 · FY2015 · CA
Clinical Research Support for the CCR
$1,940,721Robert Wiltrout · Division Of Basic Sciences - Nci · ZID · FY2012 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,939,404Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
NK cells, their receptors and unrelated donor transplant
$1,937,144Jeffrey S Miller · University Of Minnesota · P01 · FY2012 · CA
Developing Efficient and Safe Gene Transfer to Primate Hematopoietic Stem Cells
$1,934,337Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Stem Cells and Aging
$1,934,209Peter J Quesenberry · Rhode Island Hospital · P20 · FY2020 · GM
University of New Mexico Cancer Center Support
$1,934,104Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2012 · CA
University of New Mexico Cancer Center Support
$1,934,104Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2011 · CA
IATRONGENIC CAUSES OF CANCER
$1,931,218University Of Southern California · P01 · FY2002 · CA
Anti-HIV Gene Therapy: Defend and Attack
$1,929,696Irvin S.y. Chen · University Of California Los Angeles · U19 · FY2019 · AI
Targeted Sphingolipid Metabolism for Treatment of AML
$1,929,328Hong-Gang Wang · Pennsylvania State Univ Hershey Med Ctr · P01 · FY2014 · CA
Innate Immunity: Elucidation and Modulation for Cancer Therapy
$1,927,708Michael A Caligiuri · Ohio State University · P01 · FY2013 · CA
GVL without GVHD across HLA barriers: Translational Studies
$1,927,639Megan Sykes · Columbia University Health Sciences · P01 · FY2010 · CA
Development of Novel Therapeutic Strategies in Human Leukemias
$1,927,163Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2022 · CA